Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Long-term human growth hormone expression and partial phenotypic correction by plasmid-based gene therapy in an animal model of isolated growth hormone deficiency

Texto completo
Autor(es):
Oliveira, Nelio A. J. [1] ; Cecchi, Claudia R. [1] ; Higuti, Eliza [1] ; Oliveira, Joao E. [1] ; Jensen, Thomas G. [2] ; Bartolini, Paolo [1] ; Peroni, Cibele N. [1]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] IPEN CNEN, Dept Biotechnol, BR-05508900 Sao Paulo - Brazil
[2] Univ Aarhus, Inst Human Genet, Aarhus - Denmark
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: JOURNAL OF GENE MEDICINE; v. 12, n. 7, p. 580-585, JUL 2010.
Citações Web of Science: 9
Resumo

Background A model for in vivo gene therapy based on electroporation of human growth hormone (hGH)-coding naked DNA in the muscle of dwarf (lit/lit) and immunodeficient dwarf (lit/scid) mice is described. Methods A plasmid containing the ubiquitin C promoter and the genomic hGH sequence was administered to the exposed quadriceps muscle, followed by electrotransfer using eight 50-V pulses of 20 ms at a 0.5-s interval. Serum hGH levels were determined after various days of DNA administration and a long-term body weight gain experiment was carried out. Results Serum hGH, determined 3 days after DNA administration, revealed a significant dose-response curve (p < 0.01) in the 0-50 gg range. Because 50 gg of plasmid DNA produced circulating hGH levels of 2-3 ng/ml for at least 12 days, a long-term body weight gain assay was carried out. After 60 days, the weight of treated lit/scid mice increased 33.1% compared to a 4.2% weight decrease for the control group. hGH circulating levels were of the order of 1.5-3 ng/ml throughout the experiment and the average weight increase during the first 10 days was comparable to that obtained upon regular daily injection of 10 gg of recombinant hGH per mouse, producing comparable circulating levels of the hormone. A lower, but still significant increase in body weight was obtained upon repeating the experiment in immunocompetent dwarf mice (lit/lit). Conclusions We report for the first time sustained levels of circulating hGH after intramuscular naked DNA administration and, consequently, a highly significant weight increase of dwarf `little' mice. Copyright (C) 2010 John Wiley \& Sons, Ltd. (AU)

Processo FAPESP: 06/59322-3 - Enriquecimento de queratinócitos humanos em células tronco e injeção direta de DNA em camundongos anões e imunodeficiência (lit/scid), visando o desenvolvimento de modelos mais eficazes de terapia gênica para o GH
Beneficiário:Cibele Nunes Peroni
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 06/58510-0 - Enriquecimento de queratinócitos humanos em células-tronco e injeção direta de DNA em camundongos anões e imunodeficientes (lit/scid): desenvolmento de modelos animais mais eficazes de terapia gênica para hormônio de crescimento
Beneficiário:Nélio Alessandro de Jesus Oliveira
Linha de fomento: Bolsas no Brasil - Doutorado